Author archives

Nima Hosseini JAZANI

Latest posts by Nima Hosseini JAZANI (see all)

Articles signed on MÆDICA, JCM:

Frequency of the VNTR-Polymorphisms at the PAH Gene in the Iranian Azeri Turkish Patients with Phenylketonuria

SELECT ISSUE

MÆDICA - a Journal of Clinical Medicine | Vol. 10, nr. 4, 2015 CNCSIS - CMR - B+ OBBCSSR

Members Area


Frequency of the VNTR-Polymorphisms at the PAH Gene in the Iranian Azeri Turkish Patients with Phenylketonuria

, , , and

ABSTRACT

Introduction: This study was carried out to determine the frequency of the VNTR-polymorphisms at the PAH gene in the Iranian Azeri Turkish patients with phenylketonuria (PKU) and normal controls.

Material and methods: The VNTR-polymorphisms were determined by PCR in 43 PKU patients as well as 43 controls.

Outcomes: The frequencies of VNTR-alleles were 13(15.1%), 3(3.49%), 64(74.4%), 5(5.81%), and 1(1.16%) in the patients and 43(50%), 0(0%), 42(48.8%), 0(0%), and 1(1.16%) in the controls regarding 3, 7, 8, 9, and 11 repeat copies, respectively. The VNTR alleles with 12 and 13 repeats were not found in our samples. The frequencies of VNTR-genotypes were 25(58.1%), 1(2.33%), 1(2.33%), 10(23.3%), 2(4.65%), 2(4.65%), 1(2.33%), 1(2.33%), and 0(0%) in the patients and 13(30.2%), 13(30.2%), 0(0%), 16(37.2%), 0(0%), 0(0%), 0(0%), 0(0%) and 1(2.33%) in the controls regarding VNTR8/VNTR8, VNTR3/VNTR3, VNTR3/VNTR9, VNTR8/VNTR3, VNTR8/VNTR9, VNTR7/VNTR9, VNTR7/VNTR8, VNTR8/VNTR11, and VNTR3/VNTR11 genotypes, respectively. The comparisons of VNTRpolymorphisms imply that there are statistically significant differences between the patients and controls regarding VNTR3, VNTR8, and VNTR9 alleles as well as VNTR8/VNTR8 and VNTR3/VNTR3 genotypes (all P-Value <0.05). The frequency of “risk-associated genotype of VNTR8/VNTR8” was significantly higher in the cases. 

Conclusions: It is concluded that this position is heterozygous and there were statistically significant differences between patients and controls concerning the VNTR8/VNTR8 genotype. We found higher frequencies of disease-associated genotype in our samples than controls. This report is the first in its own type in the west Azerbaijani population. Further studies require assessing how this genotype predicts adverse outcomes in tested population.

Keywords: VNTR, polymorphism, PKU

Full text | PDF

Association Between PAH Mutations and VNTR Alleles in the West Azerbaijani PKU Patients

SELECT ISSUE

MÆDICA - a Journal of Clinical Medicine | Vol. 9, nr. 3, 2014

CNCSIS - CMR - B+ OBBCSSR

Association Between PAH Mutations and VNTR Alleles in the West Azerbaijani PKU Patients

, , , and

ABSTRACT

Introduction: We report the frequency of IVS10nt546, R261Q, S67P, R252W, and R408W mutations linked to PAH VNTR alleles in the west Azerbaijani PKU patients.

Material and methods: VNTR alleles and IVS10nt546, R261Q, S67P, R252W, R408W mutations were studied in a total of 20 PKU patients by PCR and RFLP-PCR.

Outcomes: Our analysis showed that 95% of cases were homozygote for an allele containing eightrepeat VNTR (VNTR8); while 5% were homozygote for an allele containing three-repeat VNTR (VNTR3). The IVS10nt546, R252W, and R261Q mutations were associated with VNTR8 allele, and also, R252W and S67P mutations were associated with VNTR3 allele. VNTR8 was common among mutant alleles as were IVS10nt546–VNTR8 (50%), R252W–VNTR8 (2.5%), and R261Q–VNTR8 (22.5%). The association of VNTR3 was found as R252W–VNTR3 (2.5%) and S67P–VNTR3 (2.5%) among studied cases. The frequency of IVS10nt546–VNTR8/IVS10nt546–VNTR8, IVS10nt546– VNTR8/ND–VNTR8, IVS10nt546–VNTR8/R252W–VNTR8, R261Q–VNTR8/R261Q–VNTR8, R261Q–VNTR8/ND–VNTR8, and S67P–VNTR3/ R252W–VNTR3 were 30%, 35%, 5%, 20%, 5%, and 5%, respectively. R408W mutation was not found in this study. Conclusions: The present report is the first in its own kind in the west Azerbaijani population (Iran) and implies that the most common PKU mutation in this population, IVS10nt546, is exclusively associated with VNTR8 allele, and IVS10nt546–VNTR8 alleles testing should be considered for routine carrier screening and prenatal diagnostic setting.

Full text | PDF